Home Healthcare Biotechnology DNA Sequencing Market

DNA Sequencing Market Size, Share & Trends Analysis Report By Offerings (Consumables, Instruments, Services), By Technology (Sanger Sequencing, Next-Generation Sequencing, Third Generation DNA Sequencing), By Applications (Oncology, Clinical investigation, Agrigenomics & forensics, HLA typing/immune system monitoring, Drug development, Others), By End-User (Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. DNA Sequencing Market, By Offerings 2022-2034 (USD MILLION/ Units)
    1. Consumables
    2. Instruments
    3. Services
  2. DNA Sequencing Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Sanger Sequencing
    2. Next-Generation Sequencing
    3. Third Generation DNA Sequencing
  3. DNA Sequencing Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Clinical investigation
    3. Agrigenomics & forensics
    4. HLA typing/immune system monitoring
    5. Drug development
    6. Others
  4. DNA Sequencing Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Academic Research
    2. Clinical Research
    3. Hospitals & Clinics
    4. Pharmaceutical & Biotechnology Companies
    5. Others
  5. Regional DNA Sequencing Market
    1. North America
      1. North America DNA Sequencing Market By Offerings 2022-2034 (USD MILLION/ Units)
        1. Consumables
        2. Instruments
        3. Services
      2. North America DNA Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Sanger Sequencing
        2. Next-Generation Sequencing
        3. Third Generation DNA Sequencing
      3. North America DNA Sequencing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Clinical investigation
        3. Agrigenomics & forensics
        4. HLA typing/immune system monitoring
        5. Drug development
        6. Others
      4. North America DNA Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Clinical Research
        3. Hospitals & Clinics
        4. Pharmaceutical & Biotechnology Companies
        5. Others
      5. U.S.
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      6. Canada
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
    2. Europe
      1. Europe DNA Sequencing Market By Offerings 2022-2034 (USD MILLION/ Units)
        1. Consumables
        2. Instruments
        3. Services
      2. Europe DNA Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Sanger Sequencing
        2. Next-Generation Sequencing
        3. Third Generation DNA Sequencing
      3. Europe DNA Sequencing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Clinical investigation
        3. Agrigenomics & forensics
        4. HLA typing/immune system monitoring
        5. Drug development
        6. Others
      4. Europe DNA Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Clinical Research
        3. Hospitals & Clinics
        4. Pharmaceutical & Biotechnology Companies
        5. Others
      5. U.K.
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      6. Germany
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      7. France
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      8. Spain
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      9. Italy
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      10. Russia
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      11. Nordic
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      12. Benelux
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      13. Rest of Europe
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
    3. APAC
      1. APAC DNA Sequencing Market By Offerings 2022-2034 (USD MILLION/ Units)
        1. Consumables
        2. Instruments
        3. Services
      2. APAC DNA Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Sanger Sequencing
        2. Next-Generation Sequencing
        3. Third Generation DNA Sequencing
      3. APAC DNA Sequencing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Clinical investigation
        3. Agrigenomics & forensics
        4. HLA typing/immune system monitoring
        5. Drug development
        6. Others
      4. APAC DNA Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Clinical Research
        3. Hospitals & Clinics
        4. Pharmaceutical & Biotechnology Companies
        5. Others
      5. China
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      6. Korea
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      7. Japan
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      8. India
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      9. Australia
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      10. Taiwan
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      11. South East Asia
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      12. Rest of Asia-Pacific
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
    4. Middle East and Africa
      1. Middle East and Africa DNA Sequencing Market By Offerings 2022-2034 (USD MILLION/ Units)
        1. Consumables
        2. Instruments
        3. Services
      2. Middle East and Africa DNA Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Sanger Sequencing
        2. Next-Generation Sequencing
        3. Third Generation DNA Sequencing
      3. Middle East and Africa DNA Sequencing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Clinical investigation
        3. Agrigenomics & forensics
        4. HLA typing/immune system monitoring
        5. Drug development
        6. Others
      4. Middle East and Africa DNA Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Clinical Research
        3. Hospitals & Clinics
        4. Pharmaceutical & Biotechnology Companies
        5. Others
      5. UAE
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      6. Turkey
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      7. Saudi Arabia
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      8. South Africa
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      9. Egypt
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      10. Nigeria
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      11. Rest of MEA
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
    5. LATAM
      1. LATAM DNA Sequencing Market By Offerings 2022-2034 (USD MILLION/ Units)
        1. Consumables
        2. Instruments
        3. Services
      2. LATAM DNA Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Sanger Sequencing
        2. Next-Generation Sequencing
        3. Third Generation DNA Sequencing
      3. LATAM DNA Sequencing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Clinical investigation
        3. Agrigenomics & forensics
        4. HLA typing/immune system monitoring
        5. Drug development
        6. Others
      4. LATAM DNA Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic Research
        2. Clinical Research
        3. Hospitals & Clinics
        4. Pharmaceutical & Biotechnology Companies
        5. Others
      5. Brazil
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      6. Mexico
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      7. Argentina
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      8. Chile
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      9. Colombia
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
      10. Rest of LATAM
        1. Consumables
        2. Instruments
        3. Services
        4. Sanger Sequencing
        5. Next-Generation Sequencing
        6. Third Generation DNA Sequencing
        7. Oncology
        8. Clinical investigation
        9. Agrigenomics & forensics
        10. HLA typing/immune system monitoring
        11. Drug development
        12. Others
        13. Academic Research
        14. Clinical Research
        15. Hospitals & Clinics
        16. Pharmaceutical & Biotechnology Companies
        17. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.